Can You Actually See a Doctor?

The NHS is caught in a system-wide capacity squeeze. The waiting list has grown from 4.4 million before the pandemic to 7.64 million, with over 300,000 people waiting more than a year for treatment. Behind that backlog lies a chain of bottlenecks: hospitals running at 92% bed occupancy (above the 85% safe maximum) with roughly 100,000 beds — down from 145,000 in 2010 — which means ambulances queue outside full A&E departments, pushing Cat 2 response times to 35 minutes against an 18-minute target. At the front door of the system, average GP waits have tripled from under 7 days in 2013 to 21 days, while each GP now covers around 2,300 patients. The NHS is delivering 76 million appointments a month. The problem is not effort but arithmetic: demand has outgrown capacity at every stage.

Life expectancy reveals something deeper than an operational crisis. For decades, the UK added roughly 0.2 years of life per year — steady, predictable progress. After 2011, that improvement stalled almost completely. Male life expectancy sits at 79.0 years, female at 83.0. COVID caused a visible dip, but the flatlining began nearly a decade earlier and has not recovered. The UK is not alone in this — similar slowdowns have appeared across wealthy nations — but the stall coincided with a period of austerity-driven cuts to public health, social care, and local government services. The causes remain debated; the trend does not.

Not everything is deteriorating. Cancer survival has improved markedly: five-year lung cancer survival has risen from 10.4% to 16.2%, breast cancer survival exceeds 85%, and melanoma survival tops 91%. These gains reflect genuine advances in screening, diagnostics, and treatment. Life expectancy, at 79 and 83 years, remains high by historical standards. The picture is one of a health system producing better clinical outcomes within an infrastructure that can no longer absorb the volume of demand placed on it.